ANPEP and neoplasm: After a 2-day exposure, bestatin (0.01–5 mg/mL) and WM15 (4, 12, and 20 μg/mL) both inhibited cell proliferation in the 4 tumor cell lines in a dose-dependent manner (Figure 1C), thus indicating that CD13 inhibition restrains the proliferation of human tumor cells.